Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomyAidan P. Noon, Mark T. Boyd, Ashraf Y. El‐Fert et al.|British Journal of Urology|2011Cited by 35